Integrated Engineering Strategies Boosting Isoprenol Biosynthesis in Serratia marcescens via Extractant Screening, Phosp
As shown in Fig. 1, the MEP pathway initiates from pyruvate and glyceraldehyde-3-phosphate, which undergo seven enzymatic steps to generate IPP, which is subsequently converted to isoprenol. However, this pathway exhibits low efficiency. For instance, (Liu et al., 2014) achieved a titer of 0.062 g/L in a 5 L fermenter after 48 h using this pathway in Escherichia coli. In contrast, the classical MV
Skip to main contentSkip to article
Published by: Elsevier
Published by
Highlights
· •First developed Serratia marcescens as a chassis for isoprenol production.
· •Engineered an endogenous phosphatase via "Energy-Evolution-Channel" strategy to enhance catalysis.
· •Integrated extractant screening, enzyme engineering, and promoter modulation for efficient fermentation.
Abstract
Isoprenol is a high-value platform chemical that has garnered significant attention in recent years as a key precursor for sustainable aviation fuel. However, the low tolerance of model microorganisms to isoprenol severely limits the efficiency of its microbial synthesis. In this study, a Serratia marcescens strain with broad-spectrum tolerance to terpenoids was employed as the chassis cell, and systematic engineering was conducted from three dimensions: in situ product detoxification, modification of key enzyme elements, and combinatorial regulation of promoters. First, by systematically evaluating the extraction partition coefficients and cell compatibility of various organic solvents, dodecanol was identified as the optimal extractant for a two-phase fermentation system, enabling in situ extraction of isoprenol during fermentation. Second, based on transcriptomic analysis, endogenous phosphatase resources were screened, and an endogenous phosphatase with isopentenyl monophosphate (IP) hydrolytic activity was identified in Serratia marcescens. Using the “Energy-Evolution-Channel (EEC)” semi-rational design strategy, a reusable framework for prioritizing mutation sites, we performed semi-rational design of this phosphatase and obtained a mutant capable of efficient isoprenol production. Subsequently, the expression levels of mevalonate kinase (MVK) in the mevalonate (MVA) pathway and the key phosphatase were regulated via differentiated promoter combinations to favor isoprenol production. Finally, the above optimization strategies were systematically integrated to construct a two-phase fermentation process. In a 5 L bioreactor with fed-batch fermentation for 96 h, the isoprenol titer reached 12.7 g/L.
Keywords
Isoprenol
;
Serratia marcescens
;
Metabolic engineering
;
Enzyme engineering
;
Two-phase fermentation
Introduction
Isoprenol (3-methyl-3-buten-1-ol) is a simple five-carbon hemiterpene alcohol belonging to the isoprenoid family. In microorganisms, isoprenol is a product of the methylerythritol phosphate (MEP) pathway or the MVA pathway, obtained through the hydrolysis of the phosphate ester bonds of isopentenyl diphosphate (IPP) or isopentenyl monophosphate (IP) by phosphatases. As a highly reactive five-carbon alcohol, isoprenol holds significant application value in the chemical industry. It can be efficiently converted into isoprene via chemical catalysis, with isoprene serving as a crucial raw material in the rubber industry and as a precursor for numerous chemical products (Emelianov et al., 2024, Kant et al., 2023). As a key intermediate in pharmaceutical and fine chemical industries, isoprenol can be utilized for the synthesis of multiple high-value products including flavor compounds (e.g., citral), vitamin A, and menthol (Babler, 2001, Shukla and Dubey, 2018). In recent years, due to its high energy density, low hygroscopicity, and high octane number (Baral et al., 2019), isoprenol has emerged as an ideal component for next-generation gasoline additives and as a biological precursor for aviation fuels (e.g., 1,4-dimethylcyclooctane) (Baral et al., 2021, Rosenkoetter et al., 2019).
Isoprenol is an important intermediate in the biosynthesis of terpenoids, particularly monoterpenes. In previous studies, isoprenol production in microorganisms has primarily relied on the MEP pathway, the classical MVA pathway, and the Haloarchaea-type MVA pathway. As shown in Fig. 1, the MEP pathway initiates from pyruvate and glyceraldehyde-3-phosphate, which undergo seven enzymatic steps to generate IPP, which is subsequently converted to isoprenol. However, this pathway exhibits low efficiency. For instance, (Liu et al., 2014) achieved a titer of 0.062 g/L in a 5 L fermenter after 48 h using this pathway in Escherichia coli. In contrast, the classical MVA pathway begins with two molecules of acetyl-CoA, which are converted to mevalonate through three steps catalyzed by acetoacetyl-CoA thiolase (AACT), HMG-CoA synthase (HMGS), and HMG-CoA reductase (HMGR), followed by three additional steps to generate IPP. Heterologous expression of this pathway in E. coli gave a titer of 1.3 g/L after 48 h of fermentation (Zheng et al., 2013). Compared to the classical MVA pathway, the Haloarchaea-type MVA pathway (VanNice et al., 2014) offers significant advantages in pathway simplification: it directly utilizes mevalonate-5-phosphate (M5P) as a substrate to generate IP, thereby bypassing the intermediate step involving IPP required in the classical pathway. Moreover, IP can be directly converted into the target product isoprenol, providing a more concise and efficient metabolic route for microbial isoprenol synthesis. This characteristic not only reduces the number of reaction steps to enhance metabolic flux but also avoids the potential toxicity and inhibition caused by IPP accumulation in the chassis cells. Consequently, this pathway has become the preferred route for microbial isoprenol synthesis in recent years and has been widely applied in metabolic engineering of various model microorganisms (Phulara et al., 2026). Early on, (Kang et al., 2016) pioneered the heterologous construction of this pathway in E. coli, successfully achieving isoprenol synthesis. Subsequently, (Kim et al., 2021) extended the application of this pathway to Saccharomyces cerevisiae to optimize metabolic flux, achieving an isoprenol titer of 0.383 g/L after 72 h of fermentation. In E. coli, (Wang et al., 2022) further conducted metabolic engineering by introducing the H-type MVA core pathway, suppressing the expression of yggV and accA genes to reduce branch pathway consumption, and overexpressing the key phosphatase aphA. Combined with fed-batch shake-flask fermentation, they achieved an isoprenol titer of 8.51 g/L after 60 h. Beyond bacteria and conventional yeasts, researchers have attempted isoprenol production in Rhodosporidium toruloides, achieving an isoprenol titer of 93.1 ± 1.7 mg/L (Garcia et al., 2026). Meanwhile, biosensor-guided strain engineering enables high-throughput screening and remarkable improvements of isoprenol biosynthesis in engineered Pseudomonas putida (Menasalvas et al., 2025). However, the production level of isoprenol via microbial synthesis remains relatively low, and existing model strains generally exhibit insufficient tolerance to this compound (Babel & Krömer, 2020).
In our previous laboratory work, a S. marcescens strain with broad-spectrum terpenoid tolerance was isolated (Liu et al., 2025), demonstrating excellent terpenoid tolerance potential. (Wang et al., 2025) integrated the Haloarchaea-type MVA pathway into this strain. In this study, using this strain as the chassis, we first systematically evaluated the extraction partition coefficients and cell compatibility of various organic extractants for isoprenol, targeting the inhibitory effect of product toxicity on cell growth. The optimal extractant for a two-phase fermentation system was selected to achieve in situ product extraction and toxicity reduction. Second, to address the enzymatic bottleneck in the hydrolysis step of the key phosphorylated intermediate (IP), we systematically screened phosphatases with potential IP hydrolysis activity guided by transcriptomic data. The EEC (Energy–Evolution–Channel) strategy is a multidimensional framework integrating structural energy evaluation, evolutionary conservation analysis and substrate tunnel analysis. It prioritizes candidate mutation sites by first assessing stability cost, followed by site screening based on sequence conservation and tunnel geometric features. Compared with conventional single-criterion screening, its merit lies in simultaneously incorporating stability, functional-site constraints and substrate accessibility to narrow down candidates (reducing the pool from all 244 full-length residues to 9 experimental sites). Guided by this strategy, we performed semi-rational design mutagenesis on the periplasmically localized endogenous phosphatase and obtained candidate mutants for subsequent fermentation evaluation. Meanwhile, we modulated the expression levels of MVK and phosphatase using promoters of varying strengths to improve isoprenol biosynthesis. Ultimately, in fed-batch fermentation conducted in a 5 L bioreactor, this study achieved an isoprenol titer of 12.7 g/L, which, to the best of our knowledge, represents the highest reported titer of this product at the fermenter scale in the literature to date.
Organizational access
Get full-text access by signing in with your organisation
Section snippets
Strain and Plasmid Construction
The plasmids and strains used in this study are listed in Supplementary Table S1. Escherichia coli JM109 was employed for cloning, plasmid construction, and preservation. Serratia marcescens TS-18 served as the initial production strain. Plasmids were transformed into S. marcescens and E. coli via electroporation and heat shock, respectively. The primers designed in this study are listed in Supplementary Table S2. All molecular biology-related enzymes were purchased from Vazyme (Nanjing,
Screening of Organic Phases for Two-Phase Fermentation
Short-chain alcohols exert severe cytotoxicity to microbial cells, and intracellular product accumulation severely restricts fermentation efficiency (Huffer et al., 2011). Isoprenol biosynthesis is particularly limited by product toxicity, which can be effectively relieved via in-situ extraction using a water-immiscible organic phase. Such two-phase fermentation systems have been widely adopted for terpenoid production to alleviate cytotoxicity, reduce product loss, and simplify downstream
Conclusion
This study systematically integrated multi-level metabolic engineering strategies for efficient isoprenol biosynthesis. Specifically, two-phase fermentation alleviated product toxicity, the EEC strategy enabled screening of superior mutants, and promoter regulation tuned key enzyme expression. The synergistic combination of these multi-pronged strategies substantially improved isoprenol production. While a high product concentration was maintained, the fermentation period was shortened,
CRediT authorship contribution statement
Tian Yang: Investigation. Xiuwen Zhou: Investigation. Qingqing Li: Writing – original draft, Visualization, Investigation. Long Wang: Visualization, Investigation, Formal analysis. Yujie Cai: Writing – review & editing, Supervision, Resources, Project administration, Conceptualization. Shengfang Wu: Investigation. Fan Tai-Ping: Investigation.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
References (46)
· D. Banerjee et al.
Genome-scale and pathway engineering for the sustainable aviation fuel precursor isoprenol production in Pseudomonas putida
Metab. Eng.
(2024)
· G. Emelianov et al.
Engineered Methylococcus capsulatus Bath for efficient methane conversion to isoprene
Bioresour. Technol.
(2024)
· A. Kang et al.
Isopentenyl diphosphate (IPP)-bypass mevalonate pathways for isopentenol production
Metab. Eng.
(2016)
· A. Kang et al.
Optimization of the IPP-bypass mevalonate pathway and fed-batch fermentation for the production of isoprenol in Escherichia coli
Metab. Eng.
(2019)
· G. Kant et al.
Enhanced bio-synthesis of isoprene via modifying mevalonate and methylerythritol phosphate pathways for industrial application: A review
Process Biochem
(2023)
· J. Kim et al.
Engineering Saccharomyces cerevisiae for isoprenol production
Metab. Eng.
(2021)
· R. León et al.
Whole-cell biocatalysis in organic media
Enzyme Microb. Technol.
(1998)
· W. Li et al.
Antibiotic-free high-yield (-)-α-bisabolol production in Serratia marcescens via metabolic engineering and genomic integration of mevalonate pathway genes
Synth. Syst. Biotechnol.
(2026)
· D. Liu et al.
Characterization and Application of a Stationary Phase Promoter Library from Serratia marcescens
ACS Synth. Biol.
(2024)
· S.C. Phulara et al.
Biotechnology of isopentenols production from microbial cell factories
Bioresour. Technol.
(2026)
Microbial production of farnesol (FOH): Current states and beyond
Process Biochem
(2011)
Improving isoprenol production via systematic CRISPRi screening in engineered Escherichia coli
Green Chem
(2022)
Engineering a robust and versatile terpenoid production platform in Serratia marcescens HBQA7
Chem. Eng. J.
(2025)
Accurate structure prediction of biomolecular interactions with AlphaFold 3
Nature
(2024)
Cloning, optimization of periplasmic expression and purification of recombinant granulocyte macrophage-stimulating factor in Escherichia coli BL21 (DE3)
Adv. Biomed. Res.
(2019)
Uni-Mol Docking V2: Towards Realistic and Accurate Binding Pose Prediction
Artificial Neural Networks and Machine Learning. ICANN 2025 International Workshops and Special Sessions
(2026)
Evolutionary engineering of E. coli MG1655 for tolerance against isoprenol
Biotechnol. Biofuels
(2020)
Greenhouse Gas Footprint, Water-Intensity, and Production Cost of Bio-Based Isopentenol as a Renewable Transportation Fuel
ACS Sustain. Chem. Eng.
(2019)
Production Cost and Carbon Footprint of Biomass-Derived Dimethylcyclooctane as a High-Performance Jet Fuel Blendstock
ACS Sustain. Chem. Eng.
(2021)
Promoter engineering: Recent advances in controlling transcription at the most fundamental level
Biotechnol. J.
(2013)
Alleviating monoterpene toxicity using a two‐phase extractive fermentation for the bioproduction of jet fuel mixtures in Saccharomyces cerevisiae
Biotechnol. Bioeng.
(2012)
Solvent Selection Strategies for Extractive Biocatalysis
Biotechnol. Prog.
(1991)
View full text
· 1
· These authors contributed equally to this work.
Persistent link using digital object identifier (DOI)
原文出处:https://www.sciencedirect.com/science/article/abs/pii/S0168165626003196?via%3Dihub
提示:本站仅汇集公开信息,版权归原作者与原发布媒体所有。
提示:本站仅汇集公开信息,版权归原作者与原发布媒体所有。